학술논문
Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.
Document Type
article
Author
Cooksey, Gail; Morales, Christina; Linde, Lauren; Schildhauer, Samuel; Guevara, Hugo; Chan, Elena; Gibb, Kathryn; Wong, Jessie; Lin, Wen; Bonin, Brandon; Arizmendi, Olivia; Lam-Hine, Tracy; Tzvieli, Ori; McDowell, Ann; Kampen, Kirstie; Lopez, Denise; Ennis, Josh; Lewis, Linda; Oren, Eyal; Hatada, April; Molinar, Blanca; Frederick, Matt; Han, George; Sanchez, Martha; Garcia, Michael; McGrath, Alana; Le, Nga; Boyd, Eric; Bertolucci, Regina; Corrigan, Jeremy; Brodine, Stephanie; Austin, Michael; Roach, William; Levin, Robert; Tyson, Brian; Pry, Jake; Cummings, Kristin; Wadford, Debra; Jain, Seema
Source
Emerging Infectious Diseases. 28(1)
Subject
Language
Abstract
State and local health departments established the California Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Respiratory Virus Sentinel Surveillance System to conduct enhanced surveillance for SARS-CoV-2 and other respiratory pathogens at sentinel outpatient testing sites in 10 counties throughout California, USA. We describe results obtained during May 10, 2020‒June 12, 2021, and compare persons with positive and negative SARS-CoV-2 PCR results by using Poisson regression. We detected SARS-CoV-2 in 1,696 (19.6%) of 8,662 specimens. Among 7,851 specimens tested by respiratory panel, rhinovirus/enterovirus was detected in 906 (11.5%) specimens and other respiratory pathogens in 136 (1.7%) specimens. We also detected 23 co-infections with SARS-CoV-2 and another pathogen. SARS-CoV-2 positivity was associated with male participants, an age of 35-49 years, Latino race/ethnicity, obesity, and work in transportation occupations. Sentinel surveillance can provide useful virologic and epidemiologic data to supplement other disease monitoring activities and might become increasingly useful as routine testing decreases.